There are a number of clear, specific advantages that set us apart from other contract development organisations.
Customer Centricity
Customer centricity is the essence of our business and is fundamental to the way we work. We believe in aligning our resources, systems and procedures for effectively catering to the needs of our customers while building mutually beneficial relationships.
Scientific Expertise
Our scientific expertise is outstanding, and is widely acknowledged. Our team is highly regarded in the pharmaceutical industry for their exceptional knowledge of dosage form development, formulation technologies and drug delivery systems.
Quick Decision Making
Given that the young and dynamic management team at Callidus are technocrats turned entrepreneurs are conscious about the fact that quick decision-making is very crucial to succeed in pharmaceutical product development space, any delay in decisions causes delays in product launch thus leads to business loss to its valued customers, this fact gives us an edge over other similar companies.
Flexibility
Our working practices are completely integrated, within our formulation, analytical and QA teams working in close partnership with each other. Unlike the large generic contract organisations, we can and do adapt to the requirements of each new client and project.
End To End Support And Absolute Responsibility
Callidus supports its valued customers by offering end-to-end product development services, right from concept-creation, design and prototyping, through technology transfer, filing of dossiers to product approvals and assistance during commercial manufacturing. Our team of technical experts are physically present at the manufacturing site right through technology transfer, stability analysis of submission batches during each time point so as to ensure seamless execution of all technology transfer activities and on time filing of dossiers.
IP Ownership
We don’t retain Intellectual Property rights, and we don’t charge royalties too. We have a policy that the entire IP generated during course of development belongs to our customer.
